University of Dundee

Latest News

June 2017

  • Yogesh Kulathu
    12 Jun 2017

    Yogesh Kulathu from the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) has been awarded a 2017 Lister Research Prize. This prestigious and highly sought-after prize is given annually by the Lister Institute of Preventive Medicine to up to five young researchers in the UK. These awards are intended to help support and nurture future leaders of biomedical research.

  • David Finlay
    08 Jun 2017

    Former Dundee researcher, Dr David Finlay, publishes recent findings in leading international journal Nature Communications. The work involved input from Dr Linda Sinclair from Professor Doreen Cantrell’s laboratory in the School who have a continuing collaboration with the Finlay group. Glucose – commonly referred to as a ‘simple’ sugar – may be a crucial factor in the fight against cancer and inflammatory disease after scientists discovered a new role for glucose in the stimulation of cells that work on the front line in the fight against infection and tumours.

  • Helge Dorfmueller
    07 Jun 2017

    Dr Helge Dorfmueller, from the Division of Molecular Microbiology, has won an award recognising the best research project funded by Tenovus Scotland. He has received the Sir Robin MacLellan Travel Award for his study 'Towards the discovery of chemical tools to prevent human infection caused by pathogenic Streptococcus pyogenes'. Dr Dorfmueller has been awarded £3000 towards the cost of travelling to a conference or symposium to enable the dissemination of Tenovus Scotland-funded research.

  • Teresa Cardote
    06 Jun 2017

    Teresa Cardote, a Ph.D. student, and Dr. Morgan Gadd, a former post-doctoral researcher in Professor Alessio Ciulli’s lab in BCDD, have had their research published in the Cell Press journal Structure. It reports a new crystal structure of a full Cullin RING E3 ligase (CRLs) complex. CRLs play important biological roles in physiology and disease, particularly in cancer, and are emerging as high-profile drug targets for the pharmaceutical industry.  

  • 05 Jun 2017

    Three researchers from the University of Dundee’s School of Life Sciences have been awarded grants totalling almost £3.5million to explore a range of subject areas. Professor Pauline Schaap has received a European Research Council (ERC) advance grant of £1.7million for her work exploring cell specialisms while Dr Constance Alabert was awarded a £1.1million ERC Early Career Stage grant to investigate the impact of DNA replication on epigenetics.

  • 02 Jun 2017

    The protein TRAF6 is essential for the operation of many physiological processes, ranging from the development of sweat glands and the formation of bone to the operation of the innate immune system.  TRAF6 is an E3 ubiquitin ligase and, for many years, it has been widely accepted that it is this enzymatic activity that mediates the essential functions of the protein.

May 2017

  • 30 May 2017

    Professor Marino Zerial from the Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany gave the Bridget Ogilvie Lecture 2017 today with a talk entitled "Mechanics in cell and tissue organization and function".

  • 29 May 2017

    Professor Tracy Palmer is stepping down as Head of Molecular Microbiology (MMB) after 8 years in the position. When Tracy took over from Geoff Gadd in 2009, the division was very much in its infancy. Over that time, Tracy has strived to form a sense of identity and instil an ethos of togetherness within the division. More widely, Tracy has made Dundee known to be a place of excellent research in microbiology to the research community. I met with Tracy to look back on her time at the helm of MMB and to look forward to the exciting new opportunities ahead.

  • 19 May 2017

    The University of Dundee has been rated among the world’s best universities in terms of impact of scientific research, being placed 28th in the 2017 CWTS Leiden Rankings.

  • 19 May 2017

    Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce that it has agreed a strategic research collaboration, and licence option agreement with Sanofi in the high-interest area of metabolic disease.  Exscientia is a spin-out company from the School.

Pages